|
C12ORF43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.754400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.905200E-01 |
| Normal-vs-Stage2 |
5.055600E-01 |
| Normal-vs-Stage3 |
2.249600E-01 |
| Normal-vs-Stage4 |
7.897000E-01 |
| Stage1-vs-Stage2 |
7.272200E-01 |
| Stage1-vs-Stage3 |
1.440420E-01 |
| Stage1-vs-Stage4 |
6.865600E-01 |
| Stage2-vs-Stage3 |
1.753420E-01 |
| Stage2-vs-Stage4 |
5.237200E-01 |
| Stage3-vs-Stage4 |
6.427400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.841600E-01 |
| Normal-vs-AfricanAmerican |
5.845400E-01 |
| Normal-vs-Asian |
9.626200E-01 |
| Caucasian-vs-AfricanAmerican |
5.941800E-01 |
| Caucasian-vs-Asian |
9.650200E-01 |
| AfricanAmerican-vs-Asian |
8.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.876800E-01 |
| Normal-vs-Female |
1.309990E-01 |
| Male-vs-Female |
8.306100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.109800E-01 |
| Normal-vs-Extreme_Weight |
1.632600E-01 |
| Normal-vs-Obese |
3.476200E-01 |
| Normal-vs-Extreme_Obese |
1.947360E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.298400E-01 |
| Normal_Weight-vs-Obese |
1.332630E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.293000E-01 |
| Extreme_Weight-vs-Obese |
6.284000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.447600E-01 |
| Obese-vs-Extreme_Obese |
1.112780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.748000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.881990E-01 |
| Normal-vs-Age(61-80Yrs) |
4.726800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.268000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.478400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.541600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.382300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.944000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.219200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.891800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.096000E-01 |
| Normal-VS-Type2 PRCC |
2.995800E-01 |
| Normal-VS-KIRP CIMP |
7.385800E-01 |
| Normal-VS-Unclassified PRCC |
1.355030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.164640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.697400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.966610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.776200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.704000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.672800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.667400E-01 |
| Normal-vs-N1 |
9.216100E-02 |
| Normal-vs-N2 |
5.872000E-01 |
| N0-vs-N1 |
2.690100E-02 |
| N0-vs-N2 |
8.805000E-01 |
| N1-vs-N2 |
3.833000E-01 |
|
|
